OKYO
Okyo Pharma·NASDAQ
--
--(--)
--
--(--)
OKYO Filings
Filing Date
Form Description
Form Type
2026-03-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-18
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-18 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-18
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-18 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-17
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-17 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
